Skip to main content
. 2004 Jan 6;90(1):20–25. doi: 10.1038/sj.bjc.6601508

Table 1. Updated efficacy results of ATAC trial with a median follow-up of 47 months.

  AN (n=3125) TAM (n=3116) AN+TAM (n=3125)
Deaths before recurrence 108 109 100
First event 413 472 488
Locoregional 84 101 107
Distant 195 222 246
CL (invasive) 20 35 30
CL (DCIS) 5 5 5

AN=anastrozole; TAM=tamoxifen; CL=contralateral breast cancer; DCIS=ductal carcinoma in situ.